Fox Run Management L.L.C. bought a new position in shares of Privia Health Group, Inc. (NASDAQ:PRVA - Free Report) in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 12,317 shares of the company's stock, valued at approximately $277,000.
Several other institutional investors and hedge funds also recently bought and sold shares of PRVA. CWM LLC grew its position in Privia Health Group by 50.3% in the 1st quarter. CWM LLC now owns 1,804 shares of the company's stock valued at $40,000 after acquiring an additional 604 shares during the last quarter. Bessemer Group Inc. increased its stake in Privia Health Group by 2,393.4% during the 1st quarter. Bessemer Group Inc. now owns 2,269 shares of the company's stock valued at $51,000 after purchasing an additional 2,178 shares in the last quarter. Russell Investments Group Ltd. lifted its position in Privia Health Group by 2,852.2% during the 1st quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company's stock worth $60,000 after acquiring an additional 2,567 shares during the period. GAMMA Investing LLC lifted its holdings in shares of Privia Health Group by 113.1% during the first quarter. GAMMA Investing LLC now owns 2,866 shares of the company's stock worth $64,000 after purchasing an additional 1,521 shares during the period. Finally, Caitong International Asset Management Co. Ltd lifted its stake in Privia Health Group by 2,115.3% during the 1st quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company's stock valued at $75,000 after acquiring an additional 3,173 shares during the period. 94.48% of the stock is owned by hedge funds and other institutional investors.
Analyst Ratings Changes
A number of analysts have recently commented on the company. JMP Securities restated a "market outperform" rating and issued a $29.00 target price on shares of Privia Health Group in a research note on Monday, April 28th. Evercore ISI decreased their price objective on shares of Privia Health Group from $30.00 to $28.00 and set an "outperform" rating on the stock in a report on Wednesday, July 9th. Zacks Research raised Privia Health Group from a "strong sell" rating to a "hold" rating in a research note on Tuesday. Barclays boosted their price target on shares of Privia Health Group from $23.00 to $24.00 and gave the stock an "equal weight" rating in a research report on Tuesday, May 27th. Finally, JPMorgan Chase & Co. upped their target price on Privia Health Group from $29.00 to $32.00 and gave the company an "overweight" rating in a report on Wednesday, May 28th. One research analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and two have issued a Hold rating to the company. Based on data from MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average price target of $28.00.
View Our Latest Stock Report on PRVA
Privia Health Group Stock Performance
Shares of NASDAQ PRVA traded up $0.66 during trading on Friday, reaching $21.99. The stock had a trading volume of 873,119 shares, compared to its average volume of 1,021,579. The company has a market cap of $2.70 billion, a P/E ratio of 199.93, a PEG ratio of 3.09 and a beta of 0.80. Privia Health Group, Inc. has a fifty-two week low of $16.47 and a fifty-two week high of $26.09. The business's 50-day moving average price is $20.94 and its 200-day moving average price is $22.71.
Privia Health Group (NASDAQ:PRVA - Get Free Report) last announced its earnings results on Thursday, August 7th. The company reported $0.02 EPS for the quarter, missing analysts' consensus estimates of $0.05 by ($0.03). The firm had revenue of $521.15 million for the quarter, compared to analysts' expectations of $466.97 million. Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. The business's revenue was up 23.4% compared to the same quarter last year. During the same quarter last year, the business earned $0.19 earnings per share. Privia Health Group has set its FY 2025 guidance at EPS. Analysts forecast that Privia Health Group, Inc. will post 0.14 EPS for the current fiscal year.
Privia Health Group Profile
(
Free Report)
Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.
Further Reading

Before you consider Privia Health Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Privia Health Group wasn't on the list.
While Privia Health Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.